Venous Thromboembolism
📧 Sign up to get email alerts when something new happens for Venous Thromboembolism.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-03-21Clinical Trial Update: Remote Home Prothrombin Time (PT)/International Normalized Ratio (INR) Monitoring and Patient Management System [NA]
A completed study assessed a remote home PT/INR monitoring and patient management system for venous thromboembolism, with results posted in …
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Elective Knee Replacement Surgery [Phase 3]
Phase 3 trial comparing AVE5026 to enoxaparin for the prevention of venous thromboembolism in patients undergoing elective knee replacement …
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Total Hip Replacement Surgery [Phase 3]
Phase 3 trial evaluating AVE5026 versus enoxaparin for prevention of venous thromboembolism in patients undergoing total hip replacement; th…
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Cancer Patients Undergoing Chemotherapy [Phase 3]
Phase 3 trial evaluating AVE5026 to prevent venous thromboembolism in cancer patients undergoing chemotherapy has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Hip Fracture Surgery [Phase 3]
Phase 3 trial comparing AVE5026 with enoxaparin for prevention of venous thromboembolism in patients undergoing hip fracture surgery has com…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients With Restricted Mobility [Phase 3]
Phase 3 trial evaluating AVE5026 for the prevention of venous thromboembolism in acutely ill medical patients with restricted mobility has b…
-
CLINICAL_TRIALS trial_result · 2013-01-15Clinical Trial Update: Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement Surgery [Phase 2]
A Phase 2 clinical trial update evaluating prevention of venous thromboembolism in patients undergoing elective total knee replacement; the …
-
CLINICAL_TRIALS trial_result · 2013-01-04Clinical Trial Update: Pradaxa (Dabigatran Etexilate) VTE Prevention After Elective Total Hip or Knee Replacement Surgery
Clinical trial update for Pradaxa (dabigatran etexilate) focusing on prevention of venous thromboembolism after elective total hip or knee r…
-
CLINICAL_TRIALS trial_result · 2012-12-20Clinical Trial Update: Clotting Genetic Variants, Hormones, and Venous Thrombosis
This clinical trial update reports on how genetic clotting variants and hormones influence the risk of venous thrombosis. The study is relev…
-
CLINICAL_TRIALS trial_result · 2012-12-06Clinical Trial Update: Risk Factors for Venous Thromboembolism in the Community
This clinical trial update reports on a completed Mayo Clinic study investigating risk factors for venous thromboembolism in the community. …
-
CLINICAL_TRIALS trial_result · 2012-09-25Clinical Trial Update: Applying Pharmacogenetic Algorithms to Individualize Dosing of Warfarin [Phase 2, Phase 3]
This update reports results from Phase 2 and Phase 3 trials evaluating pharmacogenetic algorithms to tailor warfarin dosing for thromboembol…
-
CLINICAL_TRIALS trial_result · 2012-09-13Clinical Trial Update: Prevention of Thrombosis Recurrence in Patients With Low Circulating Levels of Antithrombin.
A clinical trial update evaluating strategies to prevent recurrence of venous thrombosis in patients with low circulating antithrombin level…
-
CLINICAL_TRIALS trial_result · 2012-08-28Clinical Trial Update: Pradaxa (Dabigatran Etexilate 220 mg/q.d. in the General Population After Hip or Knee Replacement Surgery
A completed clinical trial evaluating Pradaxa (dabigatran etexilate) 220 mg once daily for prevention of venous thromboembolism after hip or…
-
CLINICAL_TRIALS trial_result · 2012-08-23Clinical Trial Update: Single IV Administration of TB-402 for Prophylaxis of Venous Thromboembolic Events (VTE) After Total Hip Replacement Surgery [Phase 2]
Phase 2 study evaluating a single intravenous dose of TB-402 for prophylaxis of venous thromboembolism after total hip replacement has been …
-
CLINICAL_TRIALS trial_result · 2012-07-25Clinical Trial Update: A Comparison of Certoparin and Unfractionated Heparin in the Prevention of Thromboembolic Events in Acutely Ill Medical Patients [Phase 3]
Phase 3 trial comparing certoparin to unfractionated heparin for prevention of thromboembolic events in acutely ill medical patients has com…
-
CLINICAL_TRIALS trial_result · 2012-07-18Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Fondaparinux for the Prevention of Venous Blood Clots in Patients With a Plaster Cast or Other Type of Immobilization for a Below-knee Injury Not Needing Surgery [Phase 3]
Phase 3 trial evaluating fondaparinux for the prevention of venous thromboembolism in patients with immobilization after a below-knee injury…
-
CLINICAL_TRIALS trial_result · 2012-07-02Clinical Trial Update: Thromboprophylaxis and Bariatric Surgery [Phase 4]
Phase 4 trial update concerning thromboprophylaxis in bariatric surgery with the current status unknown.
-
CLINICAL_TRIALS trial_result · 2012-06-27Clinical Trial Update: Venous Thromboembolic Event (VTE) Prophylaxis in Medically Ill Patients [Phase 3]
Phase 3 trial evaluating venous thromboembolism prophylaxis in medically ill patients completed; results were posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-06-14Clinical Trial Update: Phase III Study Testing Efficacy & Safety of Oral Dabigatran Etexilate vs Warfarin for 6 m Treatment for Acute Symp Venous Thromboembolism (VTE) [Phase 3]
Phase III trial comparing dabigatran etexilate with warfarin for six months of treatment in acute symptomatic venous thromboembolism has com…
-
CLINICAL_TRIALS trial_result · 2012-06-13Clinical Trial Update: Regulation of Coagulation in Orthopedic Surgery to Prevent Deep Vein Thromboembolism (DVT) and Pulmonary Embolism (PE). A Study of BAY59-7939 in the Prevention of Venous Thrombo Embolism (VTE) in Subjects Undergoing Elective Total Knee Replacement. [Phase 3]
This update reports the Phase 3 clinical trial of BAY59-7939 (rivaroxaban) for prevention of venous thromboembolism in elective total knee r…
-
CLINICAL_TRIALS trial_result · 2012-06-08Clinical Trial Update: Efficacy & Safety of Prophylaxis With Bemiparin in Cancer Patients With a Central Venous Catheter (BECAT) [Phase 3]
A Phase 3 trial evaluating bemiparin for prophylaxis of catheter-related thrombosis in cancer patients; the study (BECAT) has been terminate…
-
CLINICAL_TRIALS trial_result · 2012-06-04Clinical Trial Update: ARIXTRA Local Study For Registration In China. [Phase 3]
Phase 3 trial update for ARIXTRA evaluating prophylaxis of venous thromboembolism in knee and hip replacement patients; the study in China h…
-
CLINICAL_TRIALS trial_result · 2012-05-17Clinical Trial Update: Prediction of the Risk of Placental Vascular Pathology and Venous Thromboembolic Disease
This completed clinical trial evaluated approaches to predict the risk of placental vascular disorders and venous thromboembolism.
-
CLINICAL_TRIALS trial_result · 2012-05-03Clinical Trial Update: Epidemiology of Thromboembolism Disease: A Cohort Study
A completed cohort study investigating the epidemiology of thromboembolism disease, with results posted in May 2012, sponsored by University…
-
CLINICAL_TRIALS trial_result · 2012-04-24Clinical Trial Update: Fondaparinux 1,5 mg for the Prevention of Venous Thromboembolism (VTE) in Medical Patients With Renal Insufficiency [Phase 4]
Phase 4 trial update shows fondaparinux 1.5 mg was studied for prevention of venous thromboembolism in medical patients with renal insuffici…